Pharma: A Mexican tradeoff
While providing benefits to Mexico’s biologics system, the USMCA may also increase costs for citizens, argues Margarita Guerrero Gonzalez of Uhthoff, Gomez Vega & Uhthoff.
Latest news
Novartis acquires Japanese generics business in €400m deal
12-11-2019
Novartis has agreed to buy the Japanese business of South African generics manufacturer Aspen Pharmacare for a potential €400 million.
50 Key Influencers In The Life Sciences
- LSIPR 50 2018: Robert Nelsen 05-09-2018
- LSIPR 50 2018: Stephen Knight 04-09-2018
Regions
Sectors
